期刊论文

中文

中华检验医学杂志

1009-9158

2017

40

5

391-395

10.3760/cma.j.issn.1009-9158.2017.05.013

本校为第一机构

目的分析抗苗勒管激素(AMH)和抑制素B(INHB)诊断及评估多囊卵巢综合征(PCOS)疗效的价值。方法选择2014年1月至2016年1月湖南中医药大学第一附属医院收治的300例PCOS患者随机分为A、B及C组;A组采用中医方案治疗,B组采用西医方案治疗,C组患者采用中医联合西医方案治疗;选择同期264名健康体检者为对照。PCOS各组在治疗3个月时采用疗效分级法对患者疗效进行评价及患者治疗前后的血清AMH和INHB水平。结果AMH及INHB的最佳诊断切点分别为6.98 ng/ml和150 pg/ml,AMH及INHB联合检测较单独检测的AUC(0.945和0.859, 0.945和0.784)大。PCOS组中,与AMH、INHB比,AMH联合INHB检出率显著增高[87.00% (261/300)和...

Objective To assess the clinical diagnosis value and treatment effect of anti-Mullerian hormone (AMH) and inhibin B (INHB) in polycystic ovary syndrome (PCOS) patients. Methods Total of 300 cases of PCOS patients were enrolled in this study from January 2014 to January 2016 in the First Affiliated Hospital, Hunan University of Chinese Medicine, and those patients were randomly divided into group A, group B and group C. There were 100 patients in every group. The patients in group A were interfered by traditional Chinese medicine. The patients i...